Xenobiotic Metabolising Enzymes: Impact on Pathologic Conditions, Drug Interactions and Drug Design

被引:13
|
作者
Rekka, Eleni A. [1 ]
Kourounakis, Panos N. [1 ]
Pantelidou, Maria [2 ]
机构
[1] Aristotelian Univ Thessaloniki, Dept Pharmaceut Chem, Sch Pharm, Thessaloniki 54124, Greece
[2] Frederick Univ, Sch Hlth Sci, Dept Pharm, CY-1036 Nicosia, Cyprus
关键词
Xenobiotic metabolism phase I II III; Cytochrome P450; Drug interactions; Drug design; Drug metabolising enzyme induction inhibition; Drug metabolism and pathologic conditions; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; LIVER MICROSOMAL CYTOCHROME-P-450; ADJUVANT-INDUCED ARTHRITIS; NITRIC-OXIDE SYNTHASE; PREGNANE X RECEPTOR; OXIDATIVE STRESS; RAT-LIVER; IN-VITRO; UDP-GLUCURONOSYLTRANSFERASE; HEME OXYGENASE-1;
D O I
10.2174/1568026619666190129122727
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Background: The biotransformation of xenobiotics is a homeostatic defensive response of the body against bioactive invaders. Xenobiotic metabolizing enzymes, important for the metabolism, elimination and detoxification of exogenous agents, are found in most tissues and organs and are distinguished into phase I and phase II enzymes, as well as phase III transporters. The cytochrome P450 superfamily of enzymes plays a major role in the biotransformation of most xenobiotics as well as in the metabolism of important endogenous substrates such as steroids and fatty acids. The activity and the potential toxicity of numerous drugs are strongly influenced by their biotransformation, mainly accomplished by the cytochrome P450 enzymes, one of the most versatile enzyme systems. Objective: In this review, considering the importance of drug metabolising enzymes in health and disease, some of our previous research results are presented, which, combined with newer findings, may assist in the elucidation of xenobiotic metabolism and in the development of more efficient drugs. Conclusion: Study of drug metabolism is of major importance for the development of drugs and provides insight into the control of human health. This review is an effort towards this direction and may find useful applications in related medical interventions or help in the development of more efficient drugs.
引用
收藏
页码:276 / 291
页数:16
相关论文
共 50 条
  • [31] Induction of Xenobiotic Receptors, Transporters, and Drug Metabolizing Enzymes by Oxycodone
    Hassan, Hazem E.
    Myers, Alan L.
    Lee, Insong J.
    Mason, Clifford W.
    Wang, Duan
    Sinz, Michael W.
    Wang, Hongbing
    Eddington, Natalie D.
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (05) : 1060 - 1069
  • [32] DRUG RECEPTOR INTERACTIONS AND DRUG DESIGN
    COOPER, K
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1988, 9 (02) : 51 - 51
  • [33] Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms
    Magnus Ingelman-Sundberg
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2004, 369 : 89 - 104
  • [34] Human drug metabolising cytochrome P450 enzymes: properties and polymorphisms
    Ingelman-Sundberg, M
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 369 (01) : 89 - 104
  • [35] Changes in the expression of drug-metabolising enzymes and drug transporters in mice with collagen antibody-induced arthritis
    Fujino, Chieri
    Ueshima, Satoshi
    Katsura, Toshiya
    XENOBIOTICA, 2022, 52 (07) : 758 - 766
  • [36] TRANSCRIPTIONAL REGULATION OF DRUG METABOLISING ENZYMES: THE ROLE OF LIVER ENRICHED TRANSCRIPTION FACTORS
    Mackenzie, Peter Ian
    Gardner-Stephen, Dione
    DRUG METABOLISM REVIEWS, 2008, 40 : 18 - 18
  • [37] Prediction of cis-regulatory elements for drug-activated transcription factors in the regulation of drug-metabolising enzymes and drug transporters
    Podvinec, Michael
    Meyer, Urs A.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2006, 2 (03) : 367 - 379
  • [38] Endogenous Biomarkers to Assess Drug-Drug Interactions by Drug Transporters and Enzymes
    Mariappan, T. Thanga
    Shen, Hong
    Marathe, Punit
    CURRENT DRUG METABOLISM, 2017, 18 (08) : 757 - 768
  • [39] Coupling of conjugating enzymes and efflux transporters: Impact on bioavailability and drug interactions
    Jeong, EJ
    Liu, X
    Jia, XB
    Chen, J
    Hu, M
    CURRENT DRUG METABOLISM, 2005, 6 (05) : 455 - 468
  • [40] Enzymes as targets for Drug Design
    Palfreyman, M.G.
    Northrop, Dexter B.
    Trends in Biotechnology, 1991, 9 (03):